Our unwavering commitment ensures that they receive the highest quality assistance to achieve their goals. With a strategic vision deeply rooted in respiratory care, we specialize in the development and manufacturing of high-added-value active ingredients tailored specifically for inhalation therapies. For over two decades, Inke has led the charge in technology, driving the evolution of respiratory active pharmaceutical ingredients to meet the ever-evolving needs of patients and healthcare providers worldwide.
Respiratory Focus
Leading the way in Respiratory Care
Our dedication to excellence extends beyond substance development; it encompasses a comprehensive understanding of the complex synthesis processes inherent in respiratory medications. Leveraging our state-of-the-art multipurpose plant, meticulously designed to meet stringent regulatory standards, we ensure the highest quality and safety of our respiratory APIs.
Global Reach, Local Expertise
As a trusted partner to major generic and branded companies, Inke has solidified its position as a key supplier in the global pharmaceutical landscape. Headquartered in Barcelona, Spain, our reach extends far beyond borders, with a continuous international expansion spanning over two decades. From Europe to the United States, Japan, Korea, and China, Inke delivers cutting-edge APIs to every corner of the globe, advancing respiratory care and improving patient outcomes on a global scale.
Canada, USA & Mexico
For detailed information on this market, please reach out to Eric Bouillet.
Africa
Turkey, South Africa, MENA (Egypt, Algeria, Morocco & Tunisia)
For detailed information on this market, please reach out to Maite Pascual.
India, Bangladesh & Pakistan
For detailed information on this market, please reach out to Maite Pascual.
INKE S.A.
Main Offices:
Avinguda Diagonal, 605 6D,
08028 Barcelona, Spain
Manufacturing Site:
Area Industrial del Llobregat,
Argent 1, 08755 Castellbisbal
Barcelona, Spain
LATAM
Argentina & Brazil
For detailed information on this market, please reach out to Maite Pascual.
Asia & Oceania
China, Korea, Taiwan and Southest Asia (Vietnam, Philippines, Thailand & Malaysia), Australia & New Zealand
For detailed information on this market, please reach out to Harry Yuan.
Respiratory Focus
Discover Inke's Difference
Explore how Inke’s unparalleled expertise and unwavering commitment to respiratory health are shaping the future of inhalation therapies. Learn more about our innovative solutions and discover why leading pharmaceutical companies trust Inke as their preferred partner in respiratory care.
Respiratory APIs in the Main Markets Worldwide
USDMFs
- Aclidinium bromide
- Arformoterol tartrate (A)
- Arformoterol tartrate (D)
- Formoterol fumarate dihydrate
- Glycopyrronium bromide
- Indacaterol maleate
- Olodaterol hydrochloride
- Revefenacin trihydrate
- Salmeterol xinafoate
- Tiotropium bromide monohydrate
- Umeclidinium bromide
- Vilanterol trifenatate
CEPs/EU DMFs
- Aclidinium bromide
- Formoterol fumarate dihydrate
- Glycopyrronium bromide
- Indacaterol maleate
- Montelukast sodium
- Olodaterol hydrochloride
- Revefenacin trihydrate
- Salmeterol xinafoate
- Tiotropium bromide monohydrate
- Vilanterol trifenatate
- Umeclidinium bromide
Know more about our Respiratory Solutions
Explore Our Full Range of Respiratory APIs
Dive into our extensive product portfolio and discover the
high-quality respiratory APIs designed to meet your needs.
Access to detailed information and download product PDFs
by filling the form at the end of the page.